期刊文献+

鱼腥草热敏凝胶滴眼液的特性及临床疗效 被引量:2

Characteristics and Clinical Treatment Effect of Houttuynia Thermosensitive Gel Eye Drop
下载PDF
导出
摘要 目的观察鱼腥草热敏凝胶滴眼液的特性和临床疗效。方法以鱼腥草为主药、热敏材料泊洛沙姆407为辅料配制热敏凝胶滴眼液,测定其相转变温度、吸附量、凝胶累积溶蚀量,并与鱼腥草滴眼液和病毒唑滴眼液进行临床对照研究。结果其液态转变为凝胶的相转变温度为34.5℃,于37℃变成凝胶后其吸附量比液态滴眼液大大增加,凝胶累积溶蚀量与溶出介质加入量呈线性关系,40m in累积溶蚀量达98.76%;其临床疗效比同浓度的鱼腥草滴眼液和病毒唑滴眼液均好。结论鱼腥草热敏凝胶滴眼液是眼科长效制剂,滴眼次数少,临床疗效高。 Objective To observe the characteristics and clinical treatment effect of Houttuynia Thermosensitive Gel Eye Drop. Methods The thermosensitive eye drop was prepared with houttuynia as the principal drug and the thermosensitive material poloxamer 407 as the adjuvant drug. Then the phase transition temperature, adsorptive capacity, gel accumulative erosion rate were measured and the clinical comparative researches were done with its liquid eye drop and virazole eye drop as control, Results The phase transition temperature from liquid to gel phase was 34. 5℃. The adsorptive capacity under 37℃ at which it became gel increased obviously than liquid eye drop. The gel accumulative erosion rate showed the linear correlation with the adding amount of dissolution media. The accumulative erosion rate reached 98.76% at 40 min, It had better treatment effect than liquid eye drop and virazole control of the same concentration. Conclusion Houttuynia Thermosensitive Gel Eye Drop is a long- acting ophthalmology preparation. It can be used with fewer times and good clinical treatment effect.
出处 《中国药业》 CAS 2008年第2期44-45,共2页 China Pharmaceuticals
关键词 鱼腥草 热敏凝胶滴眼液 特性 临床疗效 houttuynia thermosensitive gel eye drop characteristics clinical treatment effect
  • 相关文献

参考文献5

二级参考文献18

  • 1赵宏章.鱼腥草注射液治疗小儿呼吸道感染200例[J].医学导报,2001,20(1):35-35.
  • 2孙思邈.银海精微[M].上海:锦章书局,1955..
  • 3Yong CS,Choi JS,Quan QZ,et al.Effect of sodium chloride on the gelation temperature,gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium[J].Int J Pharm,2001,226 (1-2):195-205.
  • 4Blonder JM,Baird L,Fulfs JC,et al.Dose -dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel[J].Life Sci,1999,65(21):261.
  • 5Wang Y,Liu S,Li CY,et al.A novel method for viral gene delivery in solid tumors[J].Cancer Res,2005,65 (17):7541-7545.
  • 6Coeshott CM,Smithson SL,Verderber E,et al.Pluronic F127-based systemic vaccine delivery systems[J].Vaccine,2004,22 (19):2396-2405.
  • 7Mansoor M,Amiji,Phung-Kim Lai,et al.Intr-Tumoraladministration of paclitaxel in an in situ gelling poloxamer 407 formulation[J].Pharmaceutical Development and Technology,2002,7 (2):195-202.
  • 8Olbrich C,Müller RH.Enzymetic degradation of SLN-effect of surfactant and surfactant mixtures[J].Int J Pharm,1999,180:31 -39.
  • 9Wei G,Xu H,Ding PT,et al.Thermosetting gels with modulated gelation temperature for ophthalmic use:rheologiccal and gamma scintigraphic studies[J].J Controlled Release,2002,83 (1):65.
  • 10Chen PC,Kohane DS,Park YJ,et al.Injectable microparticle-gel system for prolonged and localized lidocaine release.Ⅱ.In vivo anesthetic effects[J].J Biomed Mater Res A,2004,70 (3):459 -466.

共引文献24

同被引文献17

  • 1陈钢,侯世祥,刘军,栾建刚,张瑜.鼓室注射地塞米松原位凝胶的体内分布及药动学研究[J].四川大学学报(医学版),2006,37(3):456-459. 被引量:10
  • 2程海兴,王君平,孙海燕,曲华玲.泊洛沙姆407的基础和药剂学新进展[J].中国药业,2006,15(9):64-64. 被引量:9
  • 3孟江,董晓萍,姜志宏,梁士贤,赵中振.鲜鱼腥草的黄酮类化合物研究[J].中国中药杂志,2006,31(16):1335-1337. 被引量:53
  • 4贾春凤,宋艳.卡波姆的基础及药剂学上的应用[J].中国现代医药杂志,2006,8(11):152-152. 被引量:11
  • 5陈光龙,刘莹珍,廖朝峰.加替沙星热敏凝胶滴眼液家兔药效学研究[J].中国药业,2007,16(13):6-7. 被引量:6
  • 6Majid Moshirfar MD,FACS,Douglas P, marx,et al.The Effect of the Fourth- Generation Fluoroquinolones on Corneal Reepithelialization After Penetrating Keratoplasty[J].Cornea,2005;24(7):833-836.
  • 7Kowalski RP, Dhaliwal DK,Karenchak LM,et al.Gatifloxacin and moxifloxacin an in vitro suseptibility comparison to levofloxacin,ciprofloxacin and ofloxacin using bacterial keratitis isolates[J].Am J Ophthalmol,2003;136:500-505.
  • 8He C,Kim SW, Lee DS.In Situ gelling Stimuli-sensitive block copolymer hydrogels for drug delivery[J].J control Release,2008; 127(3): 189-207.
  • 9LN HR,SUNG KC,VONG WJ.ln situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine [J].Biomacrom olecules, 2004;5(6):2358-2365.
  • 10ZAKI NM,AWAD GA,MORTADA ND,et al.Enhanced bioavailability of metoclopranide HCL by intranasal administration of a mucoadhesive in situ gel with modulated theological and mucociliary transport properties[J]. Eur J pharm sci,2007;32(4-5):296-307.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部